Results 131 to 140 of about 93,225 (309)

Hydralazine-Induced Cholangitis

open access: bronze, 1984
John L. Myers, Newell A. Augur
openalex   +1 more source

Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver Transplantation

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In liver transplant recipients with coexistent inflammatory bowel disease, incidence of infectious events observed between those exposed to ‘gut‐specific’ and ‘systemic’ biologics were similar. Biologic choice should not be influenced by concerns regarding their co‐prescription with transplant immunosuppression.
Simone Chin   +8 more
wiley   +1 more source

Cholangitis due to Blastomyces dermatitidis

open access: bronze, 1989
Michael E. Ryan   +3 more
openalex   +1 more source

Emerging Trends in Patients Hospitalised With Cirrhosis—Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Rates of inpatient mortality and complication rates in cirrhosis remain high. With regard to inpatient outcomes, cirrhosis is falling behind other chronic health conditions. ABSTRACT Background The aetiologies, complications and overall burden of cirrhosis have undergone changes in recent years.
Julian Pohl   +9 more
wiley   +1 more source

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis [PDF]

open access: bronze, 1999
Ivo Graziadei   +10 more
openalex   +1 more source

Outcome After Surgery for Colon Cancer in a National Cohort of Patients With and Without Inflammatory Bowel Disease

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
This national cohort study of patients surgically resected for colon cancer, during 2007–2021, compares survival outcomes of patients with and without inflammatory bowel diseases. The main results were that overall survival, recurrence‐free survival and cancer‐specific survival were lower in patients with IBD.
Erik Lundqvist   +8 more
wiley   +1 more source

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

open access: yesBritish Journal of Haematology, EarlyView.
Inherited thrombocytopenia (IT) caused by germline variants in RUNX1, ETV6 or ANKRD26 carries a high risk of developing haematological malignancy. This study examined the clinical, platelet and molecular characteristics of 66 patients with these conditions, who carried 24 distinct genetic variants in the corresponding genes.
Ana Marín‐Quílez   +34 more
wiley   +1 more source

Home - About - Disclaimer - Privacy